Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Post by QContinuum1on Nov 21, 2024 8:40am

Weed for PTSD? F.D.A. Clears Study

The new marijuana study, funded by a $12.9 million grant from Michigan’s cannabis regulatory agency, will rely on commercially available marijuana from Canada that has a high level of THC, the ...more  
Post by Jonathon Brownon Nov 21, 2024 6:55am

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

Post by lscfaon Nov 20, 2024 5:01pm

CBD better than weight loss drugs?

Check this out...Lexaria mouse studies showed that CBD combined with its DehydraTECH technology performed better than Rybelsus, an oral form GLP-1 drug. https://lexariabioscience.com/2024 ...more  
Comment by subaru1on Nov 19, 2024 4:34pm

RE:LABS has no Debt now and $13 Million in Cash.Time to Grow :)

He should have wrote 'position us for the long wait sustainable qrowth' revenue of 3qrt were lower than the 2qrt i don't call that growth.
Post by 1hot-techwomanon Nov 19, 2024 7:22am

LABS has no Debt now and $13 Million in Cash.Time to Grow :)

“Q3 2024 was a major step in the right direction towards profitability," said CFO Greg Hunter. "Paying off our debt and rationalizing facilities, pursuing cost efficiencies while ...more  
Post by subaru1on Nov 16, 2024 12:48pm

3 qrt result

not what i was expecting top line negative compare to 2qrt, we will be back to $0,06 before the y/e results which will come in about 6 months. Speculation will go on for a while again like the last 3 ...more  
Comment by Starkickeron Nov 15, 2024 2:37pm

RE:RE:RE:Burn rate..close to 1m a quarter.

Sorry, Q3 revenue was $9.8M.
Comment by Starkickeron Nov 15, 2024 2:36pm

RE:RE:Burn rate..close to 1m a quarter.

Okay, let's cool this off a little. I think we're talking about two different things. Q3 revenue was $10.3M with an adjusted ebitda of -$748k. So they are not yet profitable, which means they ...more  
Comment by alleyesonmeon Nov 15, 2024 11:19am

RE:Burn rate..close to 1m a quarter.

Ended 2023 with 18m...paid off 2.2m =15.8m....13m sept 30th...YTD burned 2.8m divided by three quarters..933k average burn rate with one quarter to go...so again starkicker where are you getting your ...more  
Comment by QContinuum1on Nov 15, 2024 11:14am

RE:RE:RE:RE:RE:RE:Q3.

Let's focus more on the tangible current opportunities that are not being realized and less on the what-if catalysts that may or may not hit any time soon. Contrary to the belief of others ...more  
Post by alleyesonmeon Nov 15, 2024 11:10am

Burn rate..close to 1m a quarter.

Not even close to 10m...LOL how did you come up with that number starkicker? It's so ridiculous I'm done responding to you 
Comment by alleyesonmeon Nov 15, 2024 11:05am

RE:RE:RE:RE:RE:Q3.

Furthermore, 70c a share is a market cap of 300m. When you factor in epidiolex sales numbers in the U.S, and the massive chunk first to Market generics take of that...6month no competition prize for ...more  
Comment by Starkickeron Nov 15, 2024 10:58am

RE:RE:RE:RE:RE:Q3.

You justed posted their operational costs are $4M annually.  One more incorrect fact. You should follow your space buddy and mdjbrown pumper buddies and disappear as you promised.. But then, it ...more  
Comment by alleyesonmeon Nov 15, 2024 10:47am

RE:RE:RE:RE:Q3.

My stock price projections were wrong..so was every single holder of this Corp..who bought expecting the price to be unchanged years on end?...you must be forgetting as soon as the CBD FDA drug ...more  
Comment by Starkickeron Nov 15, 2024 9:58am

RE:RE:RE:RE:Q3.

Alleyes, you should keep a pretty low profile on here. In Aug 2023 you said if this wasn't at 70 cents by summer 2024 you'd leave the forum. You haven't been right about ANYTHING for three ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities